Drug intelligence / Profile preview

Xufol-Plus

Development stage
Unknown
Lead developer
Zaiva Lifesciences
Modality
Small Molecules
Administration
Oral
01

Overview

Xufol-Plus is a branded generic pharmaceutical combination product developed and marketed by Zaiva Lifesciences, an Indian pharmaceutical company. It is an oral tablet formulation designed as an enhanced version of the company's standard Xufol product. While the specific additional ingredients in the "Plus" formulation are not explicitly detailed in all available literature, the base Xufol formulation consists of L-methylfolate, methylcobalamin, and pyridoxal 5-phosphate. These components are bioactive forms of folate (Vitamin B9), Vitamin B12, and Vitamin B6, respectively. They serve as critical cofactors in the methionine cycle and the transsulfuration pathway, facilitating DNA synthesis, red blood cell maturation, and the regulation of homocysteine levels. Xufol-Plus is primarily indicated for the management of nutritional deficiencies, iron deficiency anemia, and nutritional support during pregnancy.

Brand names
Xufol-Plus
02

Targets

MTR (Methionine synthase)CBS (Cystathionine beta-synthase)DNA

Beyond the preview

Go deeper on Xufol-Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xufol-Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call